Pluri Inc.
PLUR Healthcare Biotechnology
Pluri Inc.’s revenue for fiscal 2026 (year ended June 2026) was $1.0 million, down 24.0% from fiscal 2025. In the quarter to June 2026, revenue fell 15.8%, EPS grew 48.0%, free cash flow grew 25.0% and total debt rose 3.43%, each against the same quarter a year earlier.
Follow PLUR
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
7.83 | 9.55 | 12.71 | 15.48 |
+8 more quarters Free account |
Receivables |
0.09 | 0.10 | 0.17 | 0.29 | |
Total current assets |
8.73 | 10.46 | 13.80 | 16.92 | |
Property, Plant, Equpment (Net) |
1.57 | 1.67 | 1.72 | 1.76 | |
Long-Term Investments |
1.02 | 0.95 | 0.94 | 0.91 | |
Advances, Deposits, Owenrship interests |
0.86 | 0.84 | 0.84 | — | |
Goodwill and Intangible Assets (Total) |
5.75 | 5.79 | 5.84 | 5.88 | |
Long-term assets (Other) |
0.79 | 0.82 | 0.90 | 1.44 | |
Total non-current assets |
16.15 | 15.59 | 16.79 | 16.75 | |
Total Assets |
24.88 | 26.06 | 30.60 | 33.67 | |
Accounts Payable |
2.39 | 2.13 | 2.45 | 2.19 | |
Accrued Expenses |
1.84 | 1.63 | 1.36 | 1.65 | |
Current Part of Debt |
27.43 | 27.41 | 27.78 | 27.54 | |
Other current liabilities |
0.07 | 0.23 | 0.04 | 0.11 | |
Total current liabilities |
32.72 | 32.01 | 32.35 | 32.16 | |
Long Term Debt (Total) |
0.79 | 0.43 | 0.30 | — | |
Long Term Tax Liability (Deferred) |
0.38 | 0.39 | 0.40 | 0.41 | |
Non-current Liabilities (Other) |
1.93 | 0.63 | 0.62 | 0.72 | |
Total non-current liabilities |
9.59 | 7.05 | 7.46 | 7.16 | |
Total liabilities |
42.31 | 39.06 | 39.81 | 39.32 | |
Additional Paid In Capital |
443.84 | 442.39 | 440.84 | 437.55 | |
Retained Earnings |
(466.88) | (461.00) | (455.45) | (448.90) | |
Common Equity (Total) |
(17.43) | (13.00) | (9.21) | (5.65) | |
Shareholders Equity (Total) |
(17.43) | (13.00) | (9.21) | (5.65) | |
Shareholders Equity and Liabilities (Total) |
24.88 | 26.06 | 30.60 | 33.67 | |
Shares (Common) |
10.82 | 10.43 | 9.98 | 8.16 | |
Shareholders Equity (Tangible) |
(23.18) | (18.79) | (15.05) | (11.53) | |
Net Debt |
20.39 | 18.30 | 15.38 | 12.06 | |
Total Debt |
28.23 | 27.84 | 28.08 | 27.54 |